Sun Pharma on Friday reported a consolidated net profit of Rs 888.05 crore for the fourth quarter ended March 31, 2015.
The company had posted a net profit of Rs 1,587.12 crore for the same period of the previous fiscal.
Net sales of the company stood at Rs 6,144.90 crore for the fourth quarter, while the same stood at Rs 4,043.57 crore in the year-ago period, Sun Pharmaceutical Industries said in a filing to the BSE.
For the year ended March 2015, the company posted a net profit of Rs 4,540.60 crore, while the same stood at Rs 3,141.47 crore in the last year.
Net sales of the company stood at Rs 27,286.50 crore for the year ended March 31. The same stood at Rs 16,004.39 crore in the last year.
The company said results of the quarter and year ended March 31 are not comparable to the same period of previous fiscal due to the amalgamation of Ranbaxy Laboratories with the company with effect from March 24, 2015.
Almost a year after announcing a $ 4 billion deal, Sun Pharma in March this year completed the merger of Ranbaxy with itself.
In April 2014, Sun Pharma had announced it would acquire troubled rival Ranbaxy in an all-stock transaction worth $ 4 billion that includes USD 800 million debt.
Sun Pharma shares today ended 1.05 per cent up at Rs 965.75 a piece on the BSE.
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)